1741/2682US=68 / Câncer
Loge JH, Kaasa S. Medical and psychosocial issues in Hodgkin´s disease survivors. In: Ganz PA. Cancer survivorship: today and tomorrow. New York: Springer, 2007. p. 90-100. ISBN 978-0-387-34349-5.

SOBREVIVENCIA AO CANCER; QUESTOES MEDICAS; QUESTOES PSICOSSOCIAIS; DOENCA DE HODGKIN; DOENCA DE HODGKIN. EPIDEMIOLOGIA; DOENCA DE HODGKIN. TERAPIA


1742/2682US=68 / Câncer
Ko CY, Ganz PA. Cancer survivorship issues in colorectal cancer. In: Ganz PA. Cancer survivorship: today and tomorrow. New York: Springer, 2007. p. 177-87. ISBN 978-0-387-34349-5.

SOBREVIVENCIA AO CANCER; CANCER COLORRETAL; TENDENCIAS EPIDEMIOLOGICAS; CANCER COLORRETAL. TERAPIA; QUALIDADE DE VIDA


1743/2682US=68 / Biol/Mol
Ma Y, Feng Q, Pitha-Rowe I, Kitareewan S, Dmitrovsky E. Gene profiling uncovers retinoid target genes. In: Fisher PB. Cancer genomics and proteomics: methods and protocols. New Jersey: Humana Press, 2007. p. 101-21. (Methods in Molecular Biology, 383) ISBN 978-1-58829-504-0.

TERAPIA DO CANCER; QUIMIOPREVENCAO DO CANCER; MICROARRAY; GENE PROFILING; GENES ALVO RETINOIDES; RETINOIDES; RECEPTORES NUCLEARES DE RETINOIDE; RIP140


1744/2682US=68 / Biol/Mol
Espina V, Wulfkuhle JD, Calvert VS, Petricoin III EF, Liotta LA. Reverse phase protein microarrays for monitoring biological responses. In: Fisher PB. Cancer genomics and proteomics: methods and protocols. New Jersey: Humana Press, 2007. p. 321-36. (Methods in Molecular Biology, 383) ISBN 978-1-58829-504-0.

CANCER; TERAPIA COMBINATORIA; MICRODISSECCAO CAPTURA A LASER; MICROARRAY; PERFIL MOLECULAR; PROTEINA; PROTEOMICA; HETEROGENEIDADE DO TECIDO


1745/2682US=7 / Clín/Medica
Lima MVR. UTI e procedimentos de enfermagem. In: ___. Condutas em controle de infecção hospitalar: uma abordagem simplificada. São Paulo: Iátria, 2007. p. 101-18. ISBN 85-7614-0504.

PROCEDIMENTOS DE ENFERMGEM; UTI; CONTRUCAO DE INDICADORES; UNIDADE DE TERAPIA INTENSIVA


1746/2682US=7 / Ginecologia
Alphs HH, Wu TC, Roden RBS. Prevention and treatment of cervical cancer by vaccination. In: Giordano A, Bovicelli A, Kurman RJ. Molecular pathology of gynecologic cancer. New Jersey: Humana Press, 2007. p. 125-54. (Current Clinical Oncology) ISBN 978-1-58829-453-1.

CANCER GINECOLOGICO; CANCER CERVICAL. PREVENCAO; CANCER CERVICAL. TERAPIA; VACINA; HPV; PAPILOMAVIRUS HUMANO


1747/2682US=5 / Neurologia
Keagle JN, Bradley JP. Craniofacial microsomia. In: Thaller SR, Bradley JP, Garri JI. Craniofacial surgery. New York: Informa Helthcare, 2007. p. 265-71. ISBN 978-084938210-9.

MICROSSOMIA CRANIOFACIAL; ANOMALIAS PRIMARIAS DE HEMIFACIAL; CIRURGIA MANDIBULAR; TERAPIA ORTODONTICA; CIRURGIA MAXILAR; ANOMALIAS FRONTO-ORBITO-ZIGOMATICA; RECONSTRUCAO TOTAL DA ORELHA; PARALISIA FACIAL


1748/2682US=52 / Enfermagem
Uggeri CJ, Silva CRL, Silva RCL, Meireles IB, Porto IS. Produtos e metódos terapêuticos. In: Silva RCL, Figueiredo NMA, Meireles IB, editores. Feridas: fundamentos e atualizações em enfermagem. 2ªed rev ampl. São Caetano do Sul: Yendis, 2007. p. 179-208. ISBN 85-7728007-0.

METODOS TERAPEUTICOS; PRODUTOS TERAPEUTICOS; TERAPIA HIPERBARICA; OXIGENOTERAPIA HIPERBARICA; HIPOXEMIA TECIDUAL


1749/2682US=8 / Ginecologia
Freedman RS. Immunobiology and intraperitoneal immunobiologics in ovarian cancer. In: Helm CW. Intraperitoneal cancer therapy. New Jersey: Humana Press, 2007. p. 45-54. ISBN 978-1-58829-878-2.

IMMUNOBIOLOGY; IMUNOBIOLOGICOS INTRAPERITONEAL; CANCER DE OVARIO; BIOIMMUNOTHEAPY; TERAPIA INTRAPERITONEAL


1750/2682US=82 / Biol/Mol
Schulz WA. An introduction to human cancers. In: ___. Molecular biology of human cancers: an advanced student's textbook. New York: Springer, 2007. p. 1-23. ISBN 978-1-4020-6559-0.

CANCER. INCIDENCIA; CANCER. CAUSA; CANCER. CLASSIFICACAO; CANCER. TERAPIA


1751/2682US=82 / Biol/Mol
Schulz WA. Cancer therapy. In: ___. Molecular biology of human cancers: an advanced student's textbook. New York: Springer, 2007. p. 449-87. ISBN 978-1-4020-6559-0.

CANCER. TERAPIA; QUIMIOTERAPIA; TERAPIA MEDICAMENTOSA; IMUNOTERAPIA; TERAPIA GENICA


1752/2682US=92 / Biol/Mol
Wouters BG, Chiu RK. Apoptosis and alternative modes of cell death: evaluating the importance of apoptosis and other determinants of cell death and survival. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 55-72. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

APOPTOSE; CLONOGENICA SOBREVIVENCIA; SENESCENCIA; TERAPIA DO CANCER


1753/2682US=92 / Biol/Mol
Smith DL, Nolden LK, Mills GB, Lu Y. Resistance and sensitization: chemo-and radiosensitization through inhibition of PI3K/Akt signaling. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 313-34. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

FOSFATIDILINOSITOL 3-QUINASE; AKT; SIGNALTRANSDUCTION; TERAPIA ALVO MOLECULAR; QUIMIOSSENSIBILIZACAO; RADIOSSENSIBILIZACAO


1754/2682US=92 / Biol/Mol
Deininger M. Established cancer therapies: tyrosine kinase inhibitors. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 477-508. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

TERAPIA-ALVO; BCR-ABL; FLT3; EGFR; TYROSISE INIBITORS QUINASE; IMATINIB; GEFITINIB; ERLOTINIB; CANCER; LEUCEMIA


1755/2682US=92 / Biol/Mol
Furman RR, Leonard JP, Decter J, Coleman M. Recent and developing cancer therapies: monoclonal antibodies in lymphomas. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 511-36. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

ANTICORPOS MONOCLONAIS; IMUNOTERAPIA; TERAPIA-ALVO


1756/2682US=92 / Biol/Mol
Oleinick NL, Morris RL, Nieminem AL. Recent and developing cancer therapies: photodynamic therapy-induced apoptosis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 557-78. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

TERAPIA FOTODINAMICA; FOTOSSENSIBILIZADOR; MITOCONDRIA LISOSSOMO; RETICULO ENDOPLASMATICO; APOPTOSE


1757/2682US=92 / Biol/Mol
Fulda S, Debatin KM. Recent and developing cancer therapies: modulation of TRAIL signaling for cancer therapy. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 579-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

APOPTOSE; TRAIL; DROGAS; TERAPIA DO CANCER


1758/2682US=93 / Biol/Mol
Margolin K, Clark J. Cytokines in the treatment of cancer: interleukin-2 and cancer therapy. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 307-16. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2.

CITOCINAS NO TRATAMENTO DE CANCER; INTERLEUCINA-2; TERAPIA DO CANCER


1759/2682US=93 / Biol/Mol
Bael TE, Gollob JA. Cytokines in the treatment of cancer: interleukin-12 and cancer therapy. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 317-38. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2.

CITOCINAS NO TRATAMENTO DE CANCER; INTERLEUCINA-12; TERAPIA DO CANCER


1760/2682US=93 / Biol/Mol
Cohen SM, Kaufman HL. Cytokines in the treatment of cancer: combination cytokine therapy. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 373-98. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2.

CITOCINAS NO TRATAMENTO DE CANCER; TERAPIA DE COMBINACAO DE CITOCINAS


Primeira | Anterior | Próxima | Última